BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27824706)

  • 1. Mucinous Rectal Adenocarcinoma Is Associated with a Poor Response to Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis.
    McCawley N; Clancy C; O'Neill BD; Deasy J; McNamara DA; Burke JP
    Dis Colon Rectum; 2016 Dec; 59(12):1200-1208. PubMed ID: 27824706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of mucinous rectal adenocarcinoma following preoperative chemoradiotherapy and curative surgery.
    Kim TG; Park W; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Chun HK
    Tumori; 2016; 102(1):114-21. PubMed ID: 26450451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis.
    Shin US; Yu CS; Kim JH; Kim TW; Lim SB; Yoon SN; Yoon YS; Kim CW; Kim JC
    Ann Surg Oncol; 2011 Aug; 18(8):2232-9. PubMed ID: 21347780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.
    Kang CM; Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
    Colorectal Dis; 2016 Jan; 18(1):O10-6. PubMed ID: 26530997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
    Oberholzer K; Menig M; Kreft A; Schneider A; Junginger T; Heintz A; Kreitner KF; Hötker AM; Hansen T; Düber C; Schmidberger H
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):842-8. PubMed ID: 21236593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy.
    Yu SK; Chand M; Tait DM; Brown G
    Eur J Cancer; 2014 Mar; 50(5):920-7. PubMed ID: 24440086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.
    Grillo-Ruggieri F; Mantello G; Berardi R; Cardinali M; Fenu F; Iovini G; Montisci M; Fabbietti L; Marmorale C; Guerrieri M; Saba V; Bearzi I; Mattioli R; Bonsignori M; Cascinu S
    Dis Colon Rectum; 2007 Oct; 50(10):1594-603. PubMed ID: 17846841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
    Ryan JE; Warrier SK; Lynch AC; Heriot AG
    Colorectal Dis; 2015 Oct; 17(10):849-61. PubMed ID: 26260213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.
    Barbaro B; Leccisotti L; Vecchio FM; Di Matteo M; Serra T; Salsano M; Poscia A; Coco C; Persiani R; Alfieri S; Gambacorta MA; Valentini V; Giordano A; Bonomo L
    Br J Radiol; 2017 Jan; 90(1069):20150836. PubMed ID: 27845566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
    Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
    [No Abstract]   [Full Text] [Related]  

  • 11. Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
    Reggiani Bonetti L; Lionti S; Domati F; Barresi V
    World J Gastroenterol; 2017 Feb; 23(8):1412-1423. PubMed ID: 28293088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of mucinous components in rectal cancer after preoperative chemoradiotherapy.
    Kaneko K; Kawai K; Kazama S; Murono K; Sasaki K; Yasuda K; Ohtani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Ishihara S; Morikawa T; Fukayama M; Watanabe T
    Surg Today; 2017 Jun; 47(6):697-704. PubMed ID: 27659290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Local Excision After Neoadjuvant Therapy for Rectal Cancer: Are ypT0 Tumors the Limit?
    Hallam S; Messenger DE; Thomas MG
    Dis Colon Rectum; 2016 Oct; 59(10):984-97. PubMed ID: 27602930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI.
    Oberholzer K; Menig M; Pohlmann A; Junginger T; Heintz A; Kreft A; Hansen T; Schneider A; Lollert A; Schmidberger H; Christoph D
    J Magn Reson Imaging; 2013 Jul; 38(1):119-26. PubMed ID: 23188618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer.
    Huh JW; Kim HR; Kim YJ
    Dis Colon Rectum; 2013 Jun; 56(6):698-703. PubMed ID: 23652742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Timing to Surgery after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Sun Z; Adam MA; Kim J; Shenoi M; Migaly J; Mantyh CR
    J Am Coll Surg; 2016 Apr; 222(4):367-74. PubMed ID: 26897480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma.
    Hugen N; van de Velde CJ; Bosch SL; Fütterer JJ; Elferink MA; Marijnen CA; Rutten HJ; de Wilt JH; Nagtegaal ID
    Ann Surg Oncol; 2015 Aug; 22(8):2669-76. PubMed ID: 25564178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Tumor Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy.
    Bhoday J; Smith F; Siddiqui MR; Balyasnikova S; Swift RI; Perez R; Habr-Gama A; Brown G
    Dis Colon Rectum; 2016 Oct; 59(10):925-33. PubMed ID: 27602923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is an elective diverting colostomy warranted in patients with an endoscopically obstructing rectal cancer before neoadjuvant chemotherapy?
    Patel JA; Fleshman JW; Hunt SR; Safar B; Birnbaum EH; Lin AY; Mutch MG
    Dis Colon Rectum; 2012 Mar; 55(3):249-55. PubMed ID: 22469790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.